Innovative peptides designed for enhanced skin penetration and efficacy in wound healing and skin repair. Delivered via PEGylated liposomes, these peptides promise long-lasting effects and improved skin health, targeting aging and rejuvenation.
The proposed technology involves multifunctional peptides designed for superior skin penetration and efficacy. These peptides are derived from natural proteins and target skin issues such as wound healing and skin repair. The innovation lies in the peptides' ability to deliver targeted anti-aging and skin-enhancing effects, addressing common challenges in the skincare industry like wrinkle reduction, skin smoothing, and rejuvenation. By enhancing permeability and stability, these peptides aim to outperform existing solutions, offering long-lasting benefits.
This technology is currently at Technology Readiness Level 3, indicating that it has been validated in a laboratory setting and is ready for further testing and development using in vitro methods according to OECD guidelines.
Mahindra University is a private, multidisciplinary university in Hyderabad, founded by the Mahindra Group, with a strong applied‑research ethos and industry engagement. Corporate R&D partners co‑develop research and consultancy with faculty, leveraging advanced labs to turn findings into deployable solutions. The Centre for Entrepreneurship and Innovation, working with Babson, and AIC Mahindra e‑Hub—an Atal Incubation Centre—offer incubation, mentoring, and investor access. A joint research center with Virginia Tech broadens collaborative R&D and talent pathways. Situated near Hyderabad’s T‑Hub startup ecosystem, the university connects to regional industry, while research draws competitive national funding and industry contracts.